We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
As the FDA and other drug agencies work to limit damage from a massive recall of blood pressure drugs, litigation stemming from the mess is just getting started.